AU4829190A - Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections - Google Patents

Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections

Info

Publication number
AU4829190A
AU4829190A AU48291/90A AU4829190A AU4829190A AU 4829190 A AU4829190 A AU 4829190A AU 48291/90 A AU48291/90 A AU 48291/90A AU 4829190 A AU4829190 A AU 4829190A AU 4829190 A AU4829190 A AU 4829190A
Authority
AU
Australia
Prior art keywords
prophylaxis
hepatitis
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48291/90A
Inventor
Peter M. Palese
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4829190A publication Critical patent/AU4829190A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU48291/90A 1988-12-12 1989-12-11 Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections Abandoned AU4829190A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28330388A 1988-12-12 1988-12-12
US283303 1988-12-12

Publications (1)

Publication Number Publication Date
AU4829190A true AU4829190A (en) 1990-07-10

Family

ID=23085400

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48291/90A Abandoned AU4829190A (en) 1988-12-12 1989-12-11 Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections

Country Status (5)

Country Link
EP (1) EP0452360A4 (en)
KR (1) KR910700054A (en)
AU (1) AU4829190A (en)
CA (1) CA2005192A1 (en)
WO (1) WO1990006671A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD293498A5 (en) * 1989-07-20 1991-09-05 Zi Fuer Molekularbiologie Der Adw,De METHOD FOR PRODUCING A MEDIUM FOR THE TREATMENT OR PROPHYLAXIS OF HEPATITE INFECTIONS IN HUMANS AND ANIMALS
WO1991012260A1 (en) * 1990-02-09 1991-08-22 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce 6-halo- and 2-amino-6-halo-purine 2',3'-dideoxy nucleosides and their use as antiviral agents
GB9204015D0 (en) * 1992-02-25 1992-04-08 Wellcome Found Therapeutic nucleosides
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
JP7084591B2 (en) * 2017-03-29 2022-06-15 ヤマサ醤油株式会社 A nucleoside derivative or a salt thereof, and a pharmaceutical composition containing the same.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728736A (en) * 1984-03-28 1988-03-01 Southern Research Institute Carbocyclic analogs of purine ribofuranosides
IN164556B (en) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
EP0452360A1 (en) 1991-10-23
CA2005192A1 (en) 1990-06-12
KR910700054A (en) 1991-03-13
WO1990006671A2 (en) 1990-06-28
EP0452360A4 (en) 1992-05-20

Similar Documents

Publication Publication Date Title
AU4205789A (en) Method and composition for the treatment and prevention of viral infections
AU6355090A (en) Compositions and methods for detection and treatment of epstein-barr virus infection and immune disorders
AU4032989A (en) Method and compositions for the treatment and prevention of septic shock
AU3951389A (en) The use of alpha-amino boronicacid derivatives for the prophylaxis and treatment of virus diseases
AU2407492A (en) Compounds and methods for inhibition of hiv and related viruses
AU4263789A (en) Antimalarial compositions and methods of treatment using quinidine, artemisinine and its derivatives
AU5064985A (en) Methods and compositions for treating viral infection
AU4352593A (en) Compositions for the treatment and prophylaxis of inflammations and dermatoses induced by viruses and process for the preparation thereof
AU5758594A (en) Treatment of viral infections
AU3530293A (en) Compositions for the treatment of infection and disease caused by hepatitis B virus (HBV)
AU8192691A (en) Method of treatment and compositions therefore
AU6796287A (en) Method and composition for prophylaxis and treatment of viral infections
AU7515287A (en) Methods and compositions for treating viral infections
AU4829190A (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
EP0382551A3 (en) Prevention and treatment of herpes virus infections
ZA87470B (en) Method and composition for prophylaxis and treatment of viral infections
AU4328189A (en) Bile acids for treatment of viral infections
HUT44439A (en) Process for inhibiting the reproduction of viruses and virus infections
AU3579189A (en) Acyl carnitine for the treatment and prevention of virus infections
AU7155491A (en) Compositions and methods for preventing and treating rotaviral infections
AU8497191A (en) Compositions and methods for treating hiv infections
AU6600190A (en) Therapeutic compositions; methods for treatment of hiv infections
OA09507A (en) Compositions and methods for treating or preventing AIDS ARC and HIV infection
IL96667A0 (en) Pharmaceutical compositions containing fibroblast growth factors for the prevention and treatment of viral infections
ZA897105B (en) Method and composition for the treatment of viral infections